Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Clinical Colorectal Cancer
|
February 8, 2021
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options
Benjamin E Ueberroth, Alex J Liu, Jason S Starr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2014
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
Timothy J Hobday, Rui Qin, Diane Reidy-Lagunes, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
June 21, 2006
A single-center experience with inflammatory breast cancer, 1985-2003
Rory L Smoot, Cody A Koch, Amy C Degnim, et al.
The Oncologist
|
September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score
Arif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat
Akeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Cancers
|
June 26, 2026
Small Cell and Large Cell Neuroendocrine Carcinoma of the Colon and Rectum: Population-Based Analysis of Incidence, Survival, and Site-Specific Outcomes
Nora Y Sun, Alexander H Xiao, Thorvardur R Halfdanarson, et al.
Endocrine-Related Cancer
|
May 29, 2025
Comparative efficacy of systemic therapies in malignant insulinoma
Regina Koch, Patrick Walsh McGarrah, Adrian Vella, et al.
Clinical Breast Cancer
|
October 23, 2012
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane
Kostandinos Sideras, Amylou C Dueck, Timothy J Hobday, et al.
Endocrine-Related Cancer
|
January 7, 2026
Elevated Vasoactive Intestinal Peptide Concentrations Poorly Predict VIPoma
Jack Korleski, Luis E Ospina Velasquez, Joshua Bornhorst, et al.
Breast Cancer Research and Treatment
|
August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
Grace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Clinical Colorectal Cancer
|
February 8, 2021
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options
Benjamin E Ueberroth, Alex J Liu, Jason S Starr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2014
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
Timothy J Hobday, Rui Qin, Diane Reidy-Lagunes, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
June 21, 2006
A single-center experience with inflammatory breast cancer, 1985-2003
Rory L Smoot, Cody A Koch, Amy C Degnim, et al.
The Oncologist
|
September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score
Arif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat
Akeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Cancers
|
June 26, 2026
Small Cell and Large Cell Neuroendocrine Carcinoma of the Colon and Rectum: Population-Based Analysis of Incidence, Survival, and Site-Specific Outcomes
Nora Y Sun, Alexander H Xiao, Thorvardur R Halfdanarson, et al.
Endocrine-Related Cancer
|
May 29, 2025
Comparative efficacy of systemic therapies in malignant insulinoma
Regina Koch, Patrick Walsh McGarrah, Adrian Vella, et al.
Clinical Breast Cancer
|
October 23, 2012
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane
Kostandinos Sideras, Amylou C Dueck, Timothy J Hobday, et al.
Endocrine-Related Cancer
|
January 7, 2026
Elevated Vasoactive Intestinal Peptide Concentrations Poorly Predict VIPoma
Jack Korleski, Luis E Ospina Velasquez, Joshua Bornhorst, et al.
Breast Cancer Research and Treatment
|
August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
Grace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Page
of 8